ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

QDEL vs JNJ // OPTIONS IMPLIED MOVE & PUT/CALL SKEW

QuidelOrtho Corporation (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: QDEL 0 — JNJ 9
■ METRIC PARITY
options-implied-move
—
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (QDEL VS. JNJ) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC QDEL JNJ SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 67.90% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% 25.50% -60.50 JNJ /roic <GO>
EV/EBITDA & P/E Valuation — 18.5x — TIE /valuation <GO>
Free Cash Flow Yield -8.80% 2.97% -11.77 JNJ /fcf-yield <GO>
Operating Margin -33.70% 34.70% -68.40 JNJ /operating-margins <GO>
Net Profit Margin -41.50% 28.50% -70.00 JNJ /net-margins <GO>
Revenue Growth (YoY) -1.90% 6.00% -7.90 JNJ /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 5.59 -5.39 JNJ /balance-sheet <GO>
Piotroski F-Score Quality 4/9 8/9 -4.00 JNJ /piotroski-score <GO>
Options Implied Move & Put/Call Skew ACTIVE — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 51.1 62.1 -11.03 JNJ /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 1.08 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 23.0x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $943.6M $662.49B -$661.55B JNJ /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR QDEL REV JNJ REV QDEL GROSS % JNJ GROSS % QDEL FCF JNJ FCF
FY 2025 $2.73B $94.19B — 67.9% -$83.0M $19.70B
FY 2024 $2.78B $88.82B — 69.1% -$112.1M $19.84B
FY 2023 $3.00B $85.16B — — $280.2M $18.96B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
QDEL // BETA —
JNJ // BETA 1.08